Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Goldenwell Biotech
Goldenwell Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?